Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Role of AV nodal ablation in cardiac synchronization in patients with coexistent atrial fibrillation and heart failure: a systematic review
Author: Ganesan, A.
Brooks, A.
Roberts-Thomson, K.
Lau, D.
Kalman, J.
Sanders, P.
Citation: Journal of the American College of Cardiology, 2012; 59(8):719-726
Publisher: Elsevier Science Inc
Issue Date: 2012
ISSN: 0735-1097
Organisation: Centre for Heart Rhythm Disorders
Statement of
Anand N. Ganesan, Anthony G. Brooks, Kurt C. Roberts-Thomson, Dennis H. Lau, Jonathan M. Kalman and Prashanthan Sanders
Abstract: <h4>Objectives</h4>The aim of this study was to systematically review the medical literature to evaluate the impact of AV nodal ablation in patients with heart failure and coexistent atrial fibrillation (AF) receiving cardiac resynchronization therapy (CRT).<h4>Background</h4>CRT has a substantial evidence base in patients in sinus rhythm with significant systolic dysfunction, symptomatic heart failure, and prolonged QRS duration. The role of CRT is less well established in AF patients with coexistent heart failure. AV nodal ablation has recently been suggested to improve outcomes in this group.<h4>Methods</h4>Electronic databases and reference lists through September 15, 2010, were searched. Two reviewers independently evaluated citation titles, abstracts, and articles. Studies reporting the outcomes after AV nodal ablation in patients with AF undergoing CRT for symptomatic heart failure and left ventricular dyssynchrony were selected. Data were extracted from 6 studies, including 768 CRT-AF patients, composed of 339 patients who underwent AV nodal ablation and 429 treated with medical therapy aimed at rate control alone.<h4>Results</h4>AV nodal ablation in CRT-AF patients was associated with significant reductions in all-cause mortality (risk ratio: 0.42 [95% confidence interval: 0.26 to 0.68]), cardiovascular mortality (risk ratio: 0.44 [95% confidence interval: 0.24 to 0.81]), and improvement in mean New York Heart Association functional class (risk ratio: -0.52 [95% confidence interval: -0.87 to -0.17]).<h4>Conclusions</h4>AV nodal ablation was associated with a substantial reduction in all-cause mortality and cardiovascular mortality and with improvements in New York Heart Association functional class compared with medical therapy in CRT-AF patients. Randomized controlled trials are warranted to confirm the efficacy and safety of AV nodal ablation in this patient population.
Keywords: Atrioventricular Node; Humans; Atrial Fibrillation; Catheter Ablation; Treatment Outcome; Heart Failure; Cardiac Resynchronization Therapy
Rights: © 2012 by the American College of Cardiology Foundation
RMID: 0020116755
DOI: 10.1016/j.jacc.2011.10.891
Description (link):
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.